Integrative Analysis Reveals a miRNA-mRNA Regulatory Network and Potential Causative Agents in the Asthmatic Airway

Jintao Zhang1, Zihan Wang1, Dong Zhang1

  • 1Department of Respiratory, Shandong Qianfoshan Hospital, Cheeloo College of Medicine, Shandong University, Jinan, People's Republic of China.

Abstract

Insights

This study identifies six microRNAs (miRNAs) and their target genes involved in asthma. MiR-1246 shows promise as a therapeutic target for asthma treatment and molecular subtyping.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Genetics

Background:

  • Asthma progression involves complex molecular networks, particularly microRNA (miRNA) transcriptional regulation in airway epithelium, which remains poorly understood.
  • Abnormal miRNA expression in asthmatic airway epithelium presents a growing area for developing diagnostic and therapeutic strategies for asthma.

Purpose of the Study:

  • To identify and characterize microRNAs (miRNAs) and their target genes in the airway epithelium of asthma patients.
  • To elucidate the role of specific miRNAs, particularly miR-1246, in asthma pathophysiology, including inflammation and airway remodeling.
  • To construct a preliminary epithelial regulatory network for asthma based on identified miRNA-mRNA interactions.

Main Methods:

  • Comparative analysis of airway epithelial miRNA and gene expression profiles from asthma patients and healthy subjects using three datasets.
  • Identification of differentially expressed (DE)-miRNAs and their interacting mRNAs to construct a regulatory network.
  • In vitro functional experiments to verify the involvement and functions of identified miRNAs in asthma, including the investigation of miR-1246 targets and roles.

Main Results:

  • Six microRNAs (miRNAs) and 31 validated target genes in airway epithelium associated with asthma were identified through integrative analysis.
  • In vitro functional experiments confirmed the association of these miRNAs with asthma progression, implicating them in eosinophilic inflammation and airway remodeling.
  • MiR-1246 was found to directly target POSTN, influencing epithelial-to-mesenchymal transition and fibrosis in airway epithelial cells. Other miRNAs like miR-21-5p and miR-19b-3p were also identified, with some circulating miRNAs correlating with disease status.

Conclusions:

  • A preliminary epithelial regulatory network in asthma was established, based on six identified miRNAs and their target genes.
  • The identified miRNA-mRNA interactions offer insights into the pathogenesis of asthma.
  • MiR-1246, interacting with POSTN, demonstrates multifunctional effects in asthma and emerges as a promising candidate for therapeutic intervention and molecular subtyping.

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
826
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.2K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.9K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.3K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
709